KBC Group’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
KBC Group's EXEL Position: Q2 2026 in Review
KBC Group increased its Exelixis (EXEL) stake by 54% in Q2 2026, buying an estimated $1.19M and bringing the position to 69,944 shares worth $3.81M. The position accounts for 0.01% of the portfolio, ranked #561.
KBC Group first reported a position in EXEL in Q4 2016 and has held it in 23 quarters since. The position peaked at $27.7M in Q2 2017. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- KBC Group held 69,944 shares of Exelixis worth $3.81M as of Q2 2026.
- KBC Group bought 24,472 Exelixis shares in Q2 2026, an estimated $1.19M.
- Exelixis made up 0.01% of KBC Group's portfolio in Q2 2026, its #561 holding.
- KBC Group first reported a position in Exelixis in Q4 2016 and has held it in 23 quarters since.
- KBC Group's Exelixis position peaked at $27.7M in Q2 2017.
- 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.